证券记录 · 已归档季度
MNKD
MannKind Corporation · Healthcare · Biotechnology
17被追踪持有人
-2Δ持有人
89.45M持有股份
$480.37M报告持仓市值
+1新建仓位
−3清仓
动量输入(同类管理人):
持有人广度 -10.5% ·
股份流向 -4.0% ·
净新建仓位 -11.8%
· 公式
广泛减持:持股数量下降,持有人数量减少
所有持股数据:仅限已追踪的 13F 管理人,普通股持仓,报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 106.41K | $325,595 | n/a | n/a |
| Q2 2026 | 90 | 0 | 122.90M | $522.94M | +9 | −11 |
| Q1 2026 | 95 | -6 | 143.26M | $351.80M | +6 | −12 |
| Q4 2025 | 99 | +3 | 133.27M | $755.65M | +3 | n/a |
| Q3 2025 | 17 | -2 | 89.45M | $480.37M | +1 | −3 |
| Q2 2025 | 16 | 0 | 83.27M | $311.43M | n/a | n/a |
| Q1 2025 | 13 | 0 | 35.19M | $177.04M | n/a | n/a |
| Q4 2024 | 13 | 0 | 35.66M | $229.30M | n/a | n/a |
| Q3 2024 | 12 | +1 | 19.40M | $122.05M | +1 | n/a |
| Q2 2024 | 11 | n/a | 20.14M | $105.14M | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 28.71M | -1.3% | $154.17M | 0.0% | ▼ Trim | 2 | SEC ↗ ×16 |
| 2 | The Vanguard Group ✦ (被动) | 17.63M | -2.9% | $94.68M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (被动) | 10.74M | -0.1% | $57.67M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 4 | Geode Capital Management ✦ (被动) | 7.39M | -3.0% | $39.67M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 5 | JPMorgan Chase ✦ | 4.10M | n/a | $21.99M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 6 | Morgan Stanley ✦ | 3.85M | n/a | $20.68M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 7 | Wellington Management ✦ | 3.47M | +316.2% | $18.62M | 0.0% | ▲ Add | 6 | SEC ↗ ×6 |
| 8 | Fidelity (FMR) ✦ | 3.32M | -16.0% | $17.82M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 9 | Two Sigma Investments ✦ | 2.01M | -20.4% | $10.79M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 10 | Goldman Sachs Group ✦ | 1.95M | n/a | $10.47M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 11 | Adage Capital Partners ✦ | 1.69M | 新增 | $9.10M | 0.0% | New | 1 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 1.30M | +601.1% | $6.98M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 13 | D. E. Shaw & Co. ✦ | 856.95K | -66.0% | $4.60M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 14 | Renaissance Technologies ✦ | 850.80K | -39.8% | $4.57M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 736.68K | +1513.0% | $3.96M | 0.0% | ▲ Add | 6 | SEC ↗ ×5 |
| 16 | Millennium Management ✦ | 586.54K | -86.9% | $3.15M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 267.94K | +11.1% | $1.44M | 0.0% | ▲ Add | 6 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例,即持仓信心指标。✦ = 精选管理人。
新增买入方
| Adage Capital Partners | $9.10M | 0.0% |
已清仓
| Arrowstreet Capital | $4.11M | 曾为 0.0% |
| Marshall Wace | $1.03M | 曾为 0.0% |
| Gotham Asset Management | $266,247 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构(SEC结构化数据, Q1 2026): 250 持有人, 176.45M 股份, $430.71M 已申报. 这是与上方被追踪全域数据不同的较早期间,两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券:基于共同持有计数,而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Sep 25
Binder Steven B.
Director · 39.05K 股 · $128,478
Sep 10
Binder Steven B.
Director · 33.56K 股 · $127,856
Aug 07
Binder Steven B.
Director · 39.05K 股 · $158,547
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 14
SC 13G: Rubric Capital Management LP
Jul 31
SC 13G: VANGUARD CAPITAL MANAGEMENT LLC
数据来源: 持股数据来源于已解析的13F普通股持仓(被追踪范围,变动对比集);内部人行为来自Form 3/4/5;重大持股来自Schedule 13D/13G;所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据